Health

Life Expectancy in UK and Europe Being Undermined by Obesity

Published

6 years ago

September 13, 2018

Bchcomber

LONDON – Life expectancy in Europe continues to increase but obesity and the growing proportion of people who are overweight risks reversing this trend, the World Health Organization warned Wednesday.

The World Health Organization’s director for Europe warned that “lifestyle-related risk factors” could slow or even reverse gains the continent has made in life expectancy.

In its European Health Report, covering 53 countries in a vast geographical area from the Atlantic to the Pacific, the UN agency found well-being is the highest in the world but varies widely within the region.

Average life expectancy from birth has increased from 76.7 years in 2010 to 77.8 years in 2015. Women continue to live longer than men — 81.1 years compared to 74.6 years for men, although the gap has slightly narrowed.

There are also major differences between countries. Men live almost 16 years longer in Iceland (81.4 years) than in Kazakhstan (65.7 years).

“Progress is uneven, both within and between countries, between sexes, and across generations,” said Zsuzsanna Jakab, the WHO’s director for Europe.

But she warned: “Lifestyle-related risk factors give cause for concern, as they may slow, or even reverse the great gains in life expectancy if left unchecked.”

Four in 10 Turks obese

“Overweight and obesity are on an upward trend in almost all member states,” said the report, which was launched in London.

In 2016, 23.3% of people in the region were obese, up 2.5 percentage points in six years, and 58.7% were overweight, up 2.8 points.

The trend is particularly marked in Turkey, where almost four in 10 women — 39.2% — are obese.

The WHO definition of obesity is someone with a body mass index (BMI) of more than 30, meaning more than 87 kilogrammes for someone measuring 1.7 metres.

Two other countries with a particular problem are Malta, where 29.8% of the population is obese, and Britain, where the figure is 27.8%.

The report also notes Europe has some of the highest rates of smoking and alcohol consumption in the world.

Some 29 percent of people over the age of 15 smoke, compared with 16.9% in the Americas region and 24.8% in southeast Asia.

The smokers’ figure rises to 43.4% in Greece, 39.5% in Russia and 28.1% in France, according to WHO figures from 2013.

However, the proportion of daily smokers across all the countries has dropped, from 28.1% in 2002 to 24.4% in 2014.

Alcohol consumption has fallen from the highs of the 1990s and 2000s, but at 8.6 litres per person in 2014, Europeans still drink more than other regions.

“While alcohol use is declining overall, adult consumption is still the highest in the world,” the report noted.

Among European Union nations in 2014, Lithuania had the highest average alcohol consumption at 15.2 litres per person, followed by the Czech Republic (12.7) and Belgium (12.6).

Cancer Deaths Fall

Premature deaths from cancer, diabetes, respiratory and cardio-vascular illnesses are falling, and the region is on course to reach its objective of a 1.5% annual reduction up to 2020.

Such deaths fell by nine percent between 2010 and 2015, down to 715 deaths per 100,000 inhabitants.

This is despite a growing number of cases — in the EU, new cancer diagnoses increased by 5% between 2010 and 2014, to 569 cases per 100,000 people.

Total average health spending across the region meanwhile remained “almost unchanged” at 8.2% of gross domestic product (GDP) in 2014 compared with 2010.

But there are wide variations in health coverage.

In 2014, private household payments represented 16.7% of total health spending in the EU, compared with 45.8% in Russia and 9.7% in Britain.

The report noted the growth in countries with strategies in place to reduce inequality, which have helped reduce infant mortality and vaccine coverage.

However, the WHO warned there was more to do on measles vaccinations in certain countries, including Ukraine and Montenegro.

In the UN health agency’s report, which is published every three years, it added a subjective factor — life satisfaction.

Asked how satisfied people were with life these days, the average across the region reported 5.9 out of 10.

Agence France-Presse

Health

Report Causes Pfizer Stock to Climb Approximately $1 Billion Acquired by Starboard

Published

4 months ago

October 7, 2024

Salman

(VOR News) – According to a rumor that activist investor Pfizer Starboard Value has taken a holding in the struggling pharmaceutical business that is expected to be worth around one billion dollars, the stock of Pfizer (PFE) is on the increase in premarket trading on Monday.

This comes after the report was made public. The report was made available to the general public following this. Starboard Value was successful in moving forward with the acquisition of the position.

Starboard is said to have approached Ian Read, a former chief executive officer of Pfizer, and Frank D’Amelio, a former chief financial officer, in order to seek assistance with its goals of boosting the performance of the company, according to the Wall Street Journal. Read and D’Amelio are both former Pfizer executives.

The purpose of this is to facilitate the accomplishment of its objectives, which include enhancing the overall performance of the firm.

In their previous jobs, D’Amelio and Read were chief financial officers.

It is stated in the report that the hedge fund is of the opinion that Pfizer, which is currently being managed by Albert Bourla, who succeeded Read as Chief Executive Officer (CEO) in 2019, does not demonstrate the same level of mergers and acquisitions (M&A) discipline that Read did. Bourla took over for Read in 2019. Read was succeeded by Bourla in the year 2019.

Pfizer, a multinational pharmaceutical conglomerate, has made substantial investments in the acquisition of more companies that are involved in the research and development of cancer medicines.

These businesses have been acquired for billions of dollars. The biotechnology company Seagen, which was acquired by Pfizer in the previous year for a price of $43 billion, is included in this category. One of the businesses that can be classified as belonging to this category is Seagen.

In spite of the fact that the S&P 500 Index experienced a 21% increase in 2024.

No major trading occurred in Pfizer stock that year.

Due to the fact that the demand for Pfizer’s COVID-19 vaccines fell after the firm reached its pandemic peak in 2021, the share price of the corporation has decreased by over fifty percent since that time.

This drop has occurred ever since the company’s shares reached their maximum peak, which was during the time that this decline occurred. Not only have they not changed at all, but they have also remained essentially stable. This is in contrast to the S&P 500, which has gained 21% since the beginning of this year.

Recently, the corporation was forced to take a hit when it decided to recall all of the sickle cell illness medications that it had distributed all over the world.

Fears that the prescription could lead patients to experience severe agony and possibly even death were the impetus for the decision to recall the product. In spite of the fact that Pfizer’s stock is increasing by almost three percent as a result of the news that followed the company’s decision, this is the circumstance that has come about.

SOURCE: IPN

Health

New Study Reveals Drinking Soda Pop Increases the Risk of Stroke

Published

4 months ago

October 6, 2024

VORNews

If you drink too much soda, fruit juice and coffee, beware!

A recent report from global research indicates that excessive consumption of coffee or soda pop is associated with an increased risk of stroke, although the intake of black and green tea is correlated with a reduced risk. Excessive consumption of soda pop or coffee warrants caution!

Recent research indicates that it may substantially elevate the risk of stroke.

Consuming four cups of coffee daily elevates the risk of stroke, according to studies, although ingesting 3-4 cups of black or green tea daily typically offers protection against stroke. Additionally, consume more coffee; it may reduce your risk of mortality.

Recent findings from global research studies co-led by the University of Galway and McMaster University, alongside an international consortium of stroke researchers, indicate that soda, encompassing both sugar-sweetened and artificially sweetened variants such as diet or zero sugar, is associated with a 22 percent heightened risk of stroke. The risk escalated significantly with the consumption of two or more of these beverages daily.

Stroke Risk Fizzy Drinks and Soda Pop

The correlation between fizzy drinks consumption and stroke risk was most pronounced in Europe, the Middle East, Africa, and South America. Women exhibit the most elevated risk of stroke from bleeding (intracranial hemorrhage) associated with fruit juice beverages. Consuming over 7 cups of water daily diminishes the likelihood of stroke due to a clot.

Researchers observed that numerous items advertised as fruit juice are derived from concentrates and have added sugars and preservatives, potentially negating the advantages often associated with fresh fruit and instead elevating stroke risk.

Fruit juice beverages were associated with a 37 percent heightened risk of stroke resulting from bleeding (intracranial hemorrhage). Consuming two of these beverages daily increases the risk thrice.

Consuming over four cups of coffee daily elevates the risk of stroke by 37 percent, although lower consumption levels do not correlate with stroke risk. Conversely, tea consumption was associated with an 18-20 percent reduction in stroke risk. Additionally, consuming 3-4 cups daily of black tea, such as Breakfast and Earl Grey varieties, excluding green and herbal teas, was associated with a 29 percent reduced risk of stroke.

Consuming 3-4 cups of green tea daily was associated with a 27 percent reduction in stroke risk. Notably, the addition of milk may diminish or inhibit the advantageous effects of antioxidants present in tea. The lower risk of stroke associated with tea consumption was negated for individuals who added milk.

Disclaimer: This article is intended solely for informational reasons and should not be considered a replacement for professional medical counsel. Consistently consult your physician regarding any inquiries pertaining to a medical problem.

Starbucks Faces Sales Decline Amid Price Fatigue and Rising Competition

Starbucks Faces Sales Decline Amid Price Fatigue and Rising Competition

Health

Following a Diagnosis of Breast Cancer, What Else Should You Know?

Published

4 months ago

October 5, 2024

Salman

(VOR News) – Even though breast cancer affects one in eight American women, receiving a diagnosis can make a woman feel isolated.

Experts in breast cancer from the American College of Physicians (ACS) advise patients on how to manage their disease so that they may better cope with this awful information.

First, the kind and stage of breast cancer dictates the course of your care.

In addition to immunotherapy and chemotherapy, there are various surgical options available for the treatment of breast cancer.

Women of African descent are disproportionately affected by triple-negative breast cancer, an extremely aggressive form of the disease that has never proven easy to treat.

According to the American Cancer Society, pembrolizumab (Keytruda), an immunotherapy, has been shown to be helpful when combined with chemotherapy and is currently the recommended course of treatment for certain combinations of triple-negative breast cancer.

In her presentation, Dr. Katharine Yao said, “It’s really important that the patient and physician discuss the patient’s preferences and values when deciding what type of treatment to pursue and that they have an honest, individualized discussion with their care team.”

She is currently responsible for developing breast cancer treatment recommendations for more than 575 hospitals and institutions nationwide in her role as chair of the American College of Surgeons’ National Accreditation Program for Breast Institutions (NAPBC).

Yao, vice chair of research at Endeavor Health NorthShore Hospitals in New York, pointed out that each decision made about a patient’s treatment plan should take her preferences and diagnosis into consideration.

She ought to think about whether she would prefer a mastectomy—a surgical procedure that involves removing the entire breast with or without reconstruction—or a lumpectomy, which involves a surgical procedure that spares part of the breast tissue.

She stated that “the breast cancer you have may be very different from the breast cancer you hear about in your neighbor, colleague, or friend” in a press release issued by the American Cancer Society (ACS).

“Consider that while discussing breast cancer with others.”

Throughout your journey, it is critical that you look after your emotional health because having breast cancer may have a detrimental impact on your mental health.

“Getting a cancer diagnosis does not mean that everything in your life stops to be normal.” Director of the Fellowship in the Diseases of the Breast program at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas and state head of the American Cancer Society Commission on Cancer for Arkansas, Dr. Daniela Ochoa She thinks adding the burden of a cancer diagnosis and treatment to all the other pressures in life may be taxing.

“Managing stress and emotional health is vital component of a treatment plan.”

Ochoa recommends clinically trained psychologists and social workers who have assisted people in coping with cancer to anyone receiving treatment. Learning coping techniques might also be facilitated by joining cancer support groups or cancer wellness initiatives.

Breast cancer specialists say your care team is crucial.

The American Cancer Society (ACS) defines comprehensive care as having support at every stage of the procedure from surgeons, oncologists, patient navigators, nurses, social workers, psychologists, and other specialists.

After receiving a breast cancer diagnosis, women should see a surgeon or medical oncologist to explore their options; nevertheless, treatment shouldn’t be discontinued after just one appointment or after surgery is over.

Additionally, you can ask trustworthy friends or family members to accompany you to appointments and aid you with research or notes. They could serve as a network of support for you.

Yao stated in his talk that “one of the most important things is that patients should search out a team they have confidence in, that they trust will have their back when they need it, and a team they feel they can get access to and that will help them when they are in need.”

SOURCE: MP